Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
Latham BioPharm Group (LBG), a premier provider of life science consulting services to customers in the federal and commercial sectors, today announced the expansion of company operations and the opening of new office... Read More
Recently at BioPharm America 2016 in Boston, September 13-15, biotech start-up company Asymmetrex announced its new AlphaSTEM Test contract service for counting adult tissue stem cells. In addition to applications for... Read More
The response to infection is highly variable from one individual to another. The Milieu Intérieur consortium, coordinated by Prof. Matthew Albert (Immunobiology of dendritic cells Unit, Institut Pasteur / Inserm) and Dr... Read More
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership agreement with The Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI), intended to... Read More
The PAI is a crucial step in bringing a drug to market so it’s critical to assemble the correct team to handle all of the different aspects of these inspections. Without the appropriate strategy a drug can be delayed and... Read More
Last year, Synageva Biopharma Corp. went to Alexion Pharmaceuticals Inc. in one of the year’s biggest buyouts – an $8.4 billion cash and stock deal notable for its whopping 140 percent premium. With the ink barely dry... Read More
Sofregen Medical Inc., the company pioneering silk-based medical technologies to address soft tissue defects, today announced a $6.2 million Series A financing from Polaris Partners and other founding investors who previously... Read More